Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1

Conditions

Depression 2Tobacco Use Cessation 1Smoking Cessation 1Neoplasms 1Neoplasm Metastasis 1Insulin Resistance 1Hyponatremia 1Head and Neck Neoplasms 1Depressive Disorder, Major 1Burns 1

Interventions

Escitalopram 3Sugars 2Saline Solution 2Interleukin-2 1Infliximab 1Hepatitis B Vaccines 1Esketamine 1Cognitive Behavioral Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Depression × Sugars × Clear all
NCT00536172 2023-09-21

PROTECT

University of Nebraska

Phase 4 Completed
160 enrolled 15 charts
Head & Neck

Depression, Depressive Disorder, Major, Head and Neck Neoplasms

NCT00352885 2018-09-14

Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment

Emory University

Phase 4 Completed
20 enrolled 11 charts

Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡